Giovanni Targher

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 138

Top Venues

Liver international : official journal of the International Association for the Study of the Liver

Gut

Alimentary pharmacology & therapeutics

Metabolites

This page only lists publications with an associated author ORCID identifier.

Publications

Alessandro Mantovani, Riccardo Morandin, Veronica Fiorio, Maria Giovanna Lando, Salvatore Petta, Pietro Manuel Ferraro, Giovanni Targher
Association between metabolic dysfunction-associated steatotic liver disease and risk of urolithiasis: an updated systematic review and meta-analysis. Internal and emergency medicine (2024)
Alessandro Mantovani, Riccardo Morandin, Veronica Fiorio, Maria Giovanna Lando, Alberto Gaviraghi, Leonardo Motta, Federico Gobbi, Herbert Tilg, Christopher D Byrne, Giovanni Targher
Association between MASLD and increased risk of serious bacterial infections requiring hospital admission: A meta-analysis. Liver international : official journal of the International Association for the Study of the Liver (2024)
Alessandro Mantovani, Maria Giovanna Lando, Nicolò Borella, Enrico Scoccia, Barbara Pecoraro, Federico Gobbi, Zeno Bisoffi, Luca Vittorio Valenti, Herbert Tilg, Christopher D Byrne, Giovanni Targher
Relationship between Helicobacter pylori infection and risk of metabolic dysfunction-associated steatotic liver disease: An updated meta-analysis. Liver international : official journal of the International Association for the Study of the Liver 44 (7) (2024)
Alessandro Mantovani, Fabiana Busti, Nicolò Borella, Enrico Scoccia, Barbara Pecoraro, Elena Sani, Riccardo Morandin, Alessandro Csermely, Daniele Piasentin, Elisabetta Grespan, Annalisa Castagna, Josh Bilson, Christopher D Byrne, Luca Vittorio Valenti, Domenico Girelli, Giovanni Targher
Elevated plasma hepcidin concentrations are associated with an increased risk of mortality and nonfatal cardiovascular events in patients with type 2 diabetes: a prospective study. Cardiovascular diabetology 23 (1) (2024)
Alessandro Mantovani, Alessandro Csermely, Josh Bilson, Niccolò Borella, Scoccia Enrico, Barbara Pecoraro, Emigela Shtembari, Riccardo Morandin, Stergios A Polyzos, Luca Vittorio Valenti, Herbert Tilg, Christopher D Byrne, Giovanni Targher
Association between primary hypothyroidism and metabolic dysfunction-associated steatotic liver disease: an updated meta-analysis. Gut (2024)
Grazia Pennisi, Giuseppe Infantino, Ciro Celsa, Gabriele Di Maria, Marco Enea, Marco Vaccaro, Roberto Cannella, Carlo Ciccioli, Claudia La Mantia, Alessandro Mantovani, Francesco Mercurio, Herbert Tilg, Giovanni Targher, Vito Di Marco, Calogero Cammà, Salvatore Petta
Clinical outcomes of MAFLD versus NAFLD: A meta-analysis of observational studies. Liver international : official journal of the International Association for the Study of the Liver (2024)
Xiao-Dong Zhou, Qin-Fen Chen, Giovanni Targher, Christopher D Byrne, Michael David Shapiro, Na Tian, Tie Xiao, Ki Chul Sung, Gregory Yoke Hong Lip, Ming-Hua Zheng
High-Sensitivity C-Reactive Protein Is Associated With Heart Failure Hospitalization in Patients With Metabolic Dysfunction-Associated Fatty Liver Disease and Normal Left Ventricular Ejection Fraction Undergoing Coronary Angiography. Journal of the American Heart Association (2024)
Liang-Jie Tang, Dan-Qin Sun, Sherlot Juan Song, Terry Cheuk-Fung Yip, Grace Lai-Hung Wong, Pei-Wu Zhu, Sui-Dan Chen, Morten Asser Karsdal, Diana Julie Leeming, Pei Jiang, Cong Wang, Qiang Chen, Christopher D Byrne, Giovanni Targher, Mohammed Eslam, Jacob George, Vincent Wai-Sun Wong, Ming-Hua Zheng
Serum PRO-C3 is useful for risk prediction and fibrosis assessment in MAFLD with chronic kidney disease in an Asian cohort. Liver international : official journal of the International Association for the Study of the Liver 44 (5) (2024)
Gong Feng, Na He, Jing Gao, Xiao-Cheng Li, Fen-Na Zhang, Cheng-Cheng Liu, Giovanni Targher, Christopher D Byrne, Man Mi, Ming-Hua Zheng, Feng Ye
Causal relationship between key genes and metabolic dysfunction-associated fatty liver disease risk mediated by immune cells: A Mendelian randomization and mediation analysis. Diabetes, obesity & metabolism (2024)
Salvatore Petta, Giovanni Targher, Stefano Romeo, Utpal B Pajvani, Ming-Hua Zheng, Alessio Aghemo, Luca Vittorio Valenti
The first MASH drug therapy on the horizon: Current perspectives of resmetirom. Liver international : official journal of the International Association for the Study of the Liver 44 (7) (2024)
Xiao-Dong Zhou, Cui-Fang Xu, Qin-Fen Chen, Michael D Shapiro, Gregory Yoke Hong Lip, Li-Li Chen, Giovanni Targher, Christopher D Byrne, Na Tian, Tie Xiao, Chen-Xiao Huang, Yan Ni, Ming-Hua Zheng
Serum bile acid profiles are associated with heart failure with preserved ejection fraction in patients with metabolic dysfunction-associated fatty liver disease: An exploratory study. Diabetes, obesity & metabolism 26 (9) (2024)
Alessandro Mantovani, Maria Giovanna Lando, Nicolò Borella, Enrico Scoccia, Barbara Pecoraro, Federico Gobbi, Zeno Bisoffi, Luca Vittorio Valenti, Herbert Tilg, Christopher D Byrne, Giovanni Targher
Relationship between Helicobacter pylori infection and risk of metabolic dysfunction-associated steatotic liver disease: An updated meta-analysis. Liver international : official journal of the International Association for the Study of the Liver 44 (7) (2024)
Alessandro Mantovani, Giovanni Targher
PNPLA3 variation and kidney disease. Liver international : official journal of the International Association for the Study of the Liver (2024)
Alessandro Mantovani, Alessandro Csermely, Josh Bilson, Niccolò Borella, Scoccia Enrico, Barbara Pecoraro, Emigela Shtembari, Riccardo Morandin, Stergios A Polyzos, Luca Vittorio Valenti, Herbert Tilg, Christopher D Byrne, Giovanni Targher
Association between primary hypothyroidism and metabolic dysfunction-associated steatotic liver disease: an updated meta-analysis. Gut 73 (9) (2024)
Salvatore Petta, Giovanni Targher, Stefano Romeo, Utpal B Pajvani, Ming-Hua Zheng, Alessio Aghemo, Luca Vittorio Valenti
The first MASH drug therapy on the horizon: Current perspectives of resmetirom. Liver international : official journal of the International Association for the Study of the Liver (2024)
Stergios A Polyzos, Giovanni Targher
Role of Glucocorticoids in Metabolic Dysfunction-Associated Steatotic Liver Disease. Current obesity reports 13 (2) (2024)
Valentina Giampaoli, Stefano Ballestri, Alessandro Mantovani, Giovanni Targher, Fernando Bril
Endpoints in NASH Clinical Trials: Are We Blind in One Eye? Metabolites 14 (1) (2024)
Hai-Yang Yuan, Xiao-Fei Tong, Ya-Yun Ren, Yang-Yang Li, Xin-Lei Wang, Li-Li Chen, Sui-Dan Chen, Xiao-Zhi Jin, Xiao-Dong Wang, Giovanni Targher, Christopher D Byrne, Lai Wei, Vincent W-S Wong, Dean Tai, Arun J Sanyal, Hong You, Ming-Hua Zheng
AI-based digital pathology provides newer insights into lifestyle intervention-induced fibrosis regression in MASLD: An exploratory study. Liver international : official journal of the International Association for the Study of the Liver (2024)
Xiao-Dong Zhou, Wen-Yue Liu, Giovanni Targher, Christopher D Byrne, Ming-Hua Zheng
Letter: Drug interaction in resmetirom times. Alimentary pharmacology & therapeutics 60 (4) (2024)
Xiao-Dong Zhou, Wen-Yue Liu, Giovanni Targher, Christopher D Byrne, Ming-Hua Zheng
Letter: Drug interaction in resmetirom times. Alimentary pharmacology & therapeutics (2024)
Liang-Jie Tang, Dan-Qin Sun, Sherlot Juan Song, Terry Cheuk-Fung Yip, Grace Lai-Hung Wong, Pei-Wu Zhu, Sui-Dan Chen, Morten Asser Karsdal, Diana Julie Leeming, Pei Jiang, Cong Wang, Qiang Chen, Christopher D Byrne, Giovanni Targher, Mohammed Eslam, Jacob George, Vincent Wai-Sun Wong, Ming-Hua Zheng
Serum PRO-C3 is useful for risk prediction and fibrosis assessment in MAFLD with chronic kidney disease in an Asian cohort. Liver international : official journal of the International Association for the Study of the Liver 44 (5) (2024)
Xiao-Dong Zhou, Qin-Fen Chen, Giovanni Targher, Christopher D Byrne, Michael David Shapiro, Na Tian, Tie Xiao, Ki Chul Sung, Gregory Yoke Hong Lip, Ming-Hua Zheng
High-Sensitivity C-Reactive Protein Is Associated With Heart Failure Hospitalization in Patients With Metabolic Dysfunction-Associated Fatty Liver Disease and Normal Left Ventricular Ejection Fraction Undergoing Coronary Angiography. Journal of the American Heart Association 13 (3) (2024)
Salvatore Petta, Giovanni Targher, Stefano Romeo, Utpal B Pajvani, Ming-Hua Zheng, Alessio Aghemo, Luca Vittorio Valenti
The first MASH drug therapy on the horizon: Current perspectives of resmetirom. Liver international : official journal of the International Association for the Study of the Liver 44 (7) (2024)
Alessandro Mantovani, Fabiana Busti, Nicolò Borella, Enrico Scoccia, Barbara Pecoraro, Elena Sani, Riccardo Morandin, Alessandro Csermely, Daniele Piasentin, Elisabetta Grespan, Annalisa Castagna, Josh Bilson, Christopher D Byrne, Luca Vittorio Valenti, Domenico Girelli, Giovanni Targher
Elevated plasma hepcidin concentrations are associated with an increased risk of mortality and nonfatal cardiovascular events in patients with type 2 diabetes: a prospective study. Cardiovascular diabetology 23 (1) (2024)
Xiao-Dong Zhou, Seung-Up Kim, Terry Cheuk Fung Yip, Salvatore Petta, Atsushi Nakajima, Emmanuel Tsochatzis, Jérôme Boursier, Elisabetta Bugianesi, Hannes Hagström, Wah-Kheong Chan, Manuel Romero, Jose Luis Calleja, Victor de Lédinghen, Laurent Castéra, Arun J Sanyal, George Boon-Bee Goh, Philip Noel Newsome, Jiangao Fan, Michelle Lai, Céline Fournier-Poizat, Hye-Won Lee, Grace Lai-Hung Wong, Angelo Armandi, Ying Shang, Grazia Pennisi, Elba Llop, Masato Yoneda, Marc de Saint-Loup, Clémence M Canivet, Carmen Lara-Romero, Rocio Gallego-Duràn, Amon Asgharpour, Kevin Kim-Jun Teh, Sara Mahgoub, Mandy Sau-Wai Chan, Huapeng Lin, Wen-Yue Liu, Giovanni Targher, Christopher D Byrne, Vincent Wai-Sun Wong, Ming-Hua Zheng, null null
Long-term liver-related outcomes and liver stiffness progression of statin usage in steatotic liver disease. Gut (2024)
Christopher D Byrne, Giovanni Targher, Herbert Tilg
Thyroid hormone receptor-beta agonists: new MASLD therapies on the horizon. Gut (2024)
Stergios A Polyzos, Giovanni Targher
Role of Glucocorticoids in Metabolic Dysfunction-Associated Steatotic Liver Disease. Current obesity reports 13 (2) (2024)
Giovanni Targher, Christopher D Byrne, Herbert Tilg
MASLD: a systemic metabolic disorder with cardiovascular and malignant complications. Gut (2024)
Alessandro Mantovani, Alessandro Csermely, Josh Bilson, Niccolò Borella, Scoccia Enrico, Barbara Pecoraro, Emigela Shtembari, Riccardo Morandin, Stergios A Polyzos, Luca Vittorio Valenti, Herbert Tilg, Christopher D Byrne, Giovanni Targher
Association between primary hypothyroidism and metabolic dysfunction-associated steatotic liver disease: an updated meta-analysis. Gut 73 (9) (2024)
Xiao-Dong Zhou, Qin-Fen Chen, Giovanni Targher, Christopher D Byrne, Michael David Shapiro, Na Tian, Tie Xiao, Ki Chul Sung, Gregory Yoke Hong Lip, Ming-Hua Zheng
High-Sensitivity C-Reactive Protein Is Associated With Heart Failure Hospitalization in Patients With Metabolic Dysfunction-Associated Fatty Liver Disease and Normal Left Ventricular Ejection Fraction Undergoing Coronary Angiography. Journal of the American Heart Association 13 (3) (2024)
Liang-Jie Tang, Dan-Qin Sun, Sherlot Juan Song, Terry Cheuk-Fung Yip, Grace Lai-Hung Wong, Pei-Wu Zhu, Sui-Dan Chen, Morten Asser Karsdal, Diana Julie Leeming, Pei Jiang, Cong Wang, Qiang Chen, Christopher D Byrne, Giovanni Targher, Mohammed Eslam, Jacob George, Vincent Wai-Sun Wong, Ming-Hua Zheng
Serum PRO-C3 is useful for risk prediction and fibrosis assessment in MAFLD with chronic kidney disease in an Asian cohort. Liver international : official journal of the International Association for the Study of the Liver (2024)
Valentina Giampaoli, Stefano Ballestri, Alessandro Mantovani, Giovanni Targher, Fernando Bril
Endpoints in NASH Clinical Trials: Are We Blind in One Eye? Metabolites 14 (1) (2024)
Stergios A Polyzos, Giovanni Targher
Role of Glucocorticoids in Metabolic Dysfunction-Associated Steatotic Liver Disease. Current obesity reports 13 (2) (2024)
Giovanni Targher, Christopher D Byrne, Herbert Tilg
MASLD: a systemic metabolic disorder with cardiovascular and malignant complications. Gut 73 (4) (2024)
Liang-Jie Tang, Dan-Qin Sun, Sherlot Juan Song, Terry Cheuk-Fung Yip, Grace Lai-Hung Wong, Pei-Wu Zhu, Sui-Dan Chen, Morten Asser Karsdal, Diana Julie Leeming, Pei Jiang, Cong Wang, Qiang Chen, Christopher D Byrne, Giovanni Targher, Mohammed Eslam, Jacob George, Vincent Wai-Sun Wong, Ming-Hua Zheng
Serum PRO-C3 is useful for risk prediction and fibrosis assessment in MAFLD with chronic kidney disease in an Asian cohort. Liver international : official journal of the International Association for the Study of the Liver 44 (5) (2024)
Salvatore Petta, Giovanni Targher, Stefano Romeo, Utpal B Pajvani, Ming-Hua Zheng, Alessio Aghemo, Luca Vittorio Valenti
The first MASH drug therapy on the horizon: Current perspectives of resmetirom. Liver international : official journal of the International Association for the Study of the Liver 44 (7) (2024)
Xiao-Dong Zhou, Qin-Fen Chen, Giovanni Targher, Christopher D Byrne, Michael David Shapiro, Na Tian, Tie Xiao, Ki Chul Sung, Gregory Yoke Hong Lip, Ming-Hua Zheng
High-Sensitivity C-Reactive Protein Is Associated With Heart Failure Hospitalization in Patients With Metabolic Dysfunction-Associated Fatty Liver Disease and Normal Left Ventricular Ejection Fraction Undergoing Coronary Angiography. Journal of the American Heart Association 13 (3) (2024)
Stergios A Polyzos, Giovanni Targher
Role of Glucocorticoids in Metabolic Dysfunction-Associated Steatotic Liver Disease. Current obesity reports (2024)
Alessandro Mantovani, Maria Giovanna Lando, Nicolò Borella, Enrico Scoccia, Barbara Pecoraro, Federico Gobbi, Zeno Bisoffi, Luca Vittorio Valenti, Herbert Tilg, Christopher D Byrne, Giovanni Targher
Relationship between Helicobacter pylori infection and risk of metabolic dysfunction-associated steatotic liver disease: An updated meta-analysis. Liver international : official journal of the International Association for the Study of the Liver (2024)
Giovanni Targher, Christopher D Byrne, Herbert Tilg
MASLD: a systemic metabolic disorder with cardiovascular and malignant complications. Gut 73 (4) (2024)
Christopher D Byrne, Giovanni Targher, Herbert Tilg
Thyroid hormone receptor-beta agonists: new MASLD therapies on the horizon. Gut 73 (4) (2024)
Giovanni Targher, Christopher D Byrne, Herbert Tilg
MASLD: a systemic metabolic disorder with cardiovascular and malignant complications. Gut 73 (4) (2024)
Alessandro Mantovani, Fabiana Busti, Nicolò Borella, Enrico Scoccia, Barbara Pecoraro, Elena Sani, Riccardo Morandin, Alessandro Csermely, Daniele Piasentin, Elisabetta Grespan, Annalisa Castagna, Josh Bilson, Christopher D Byrne, Luca Vittorio Valenti, Domenico Girelli, Giovanni Targher
Elevated plasma hepcidin concentrations are associated with an increased risk of mortality and nonfatal cardiovascular events in patients with type 2 diabetes: a prospective study. Cardiovascular diabetology 23 (1) (2024)
Xiao-Dong Zhou, Qin-Fen Chen, Giovanni Targher, Christopher D Byrne, Michael David Shapiro, Na Tian, Tie Xiao, Ki Chul Sung, Gregory Yoke Hong Lip, Ming-Hua Zheng
High-Sensitivity C-Reactive Protein Is Associated With Heart Failure Hospitalization in Patients With Metabolic Dysfunction-Associated Fatty Liver Disease and Normal Left Ventricular Ejection Fraction Undergoing Coronary Angiography. Journal of the American Heart Association 13 (3) (2024)
Alessandro Mantovani, Maria Giovanna Lando, Nicolò Borella, Enrico Scoccia, Barbara Pecoraro, Federico Gobbi, Zeno Bisoffi, Luca Vittorio Valenti, Herbert Tilg, Christopher D Byrne, Giovanni Targher
Relationship between Helicobacter pylori infection and risk of metabolic dysfunction-associated steatotic liver disease: An updated meta-analysis. Liver international : official journal of the International Association for the Study of the Liver 44 (7) (2024)
Xiao-Dong Zhou, Cui-Fang Xu, Qin-Fen Chen, Michael D Shapiro, Gregory Yoke Hong Lip, Li-Li Chen, Giovanni Targher, Christopher D Byrne, Na Tian, Tie Xiao, Chen-Xiao Huang, Yan Ni, Ming-Hua Zheng
Serum bile acid profiles are associated with heart failure with preserved ejection fraction in patients with metabolic dysfunction-associated fatty liver disease: An exploratory study. Diabetes, obesity & metabolism (2024)
Valentina Giampaoli, Stefano Ballestri, Alessandro Mantovani, Giovanni Targher, Fernando Bril
Endpoints in NASH Clinical Trials: Are We Blind in One Eye? Metabolites 14 (1) (2024)
Hai-Yang Yuan, Wen-Yue Liu, Gong Feng, Sui-Dan Chen, Xin-Zhe Jin, Li-Li Chen, Zi-Jun Song, Ke Li, Christopher D Byrne, Giovanni Targher, Na Tian, Gang Li, Xin-Lei Zhang, Jacob George, Meng Zhou, Fudi Wang, Ming-Hua Zheng
Associations between cuprotosis-related genes and the spectrum of metabolic dysfunction-associated fatty liver disease: An exploratory study. Diabetes, obesity & metabolism (2024)
Christopher D Byrne, Giovanni Targher, Herbert Tilg
Thyroid hormone receptor-beta agonists: new MASLD therapies on the horizon. Gut 73 (4) (2024)
Liang-Jie Tang, Dan-Qin Sun, Sherlot Juan Song, Terry Cheuk-Fung Yip, Grace Lai-Hung Wong, Pei-Wu Zhu, Sui-Dan Chen, Morten Asser Karsdal, Diana Julie Leeming, Pei Jiang, Cong Wang, Qiang Chen, Christopher D Byrne, Giovanni Targher, Mohammed Eslam, Jacob George, Vincent Wai-Sun Wong, Ming-Hua Zheng
Serum PRO-C3 is useful for risk prediction and fibrosis assessment in MAFLD with chronic kidney disease in an Asian cohort. Liver international : official journal of the International Association for the Study of the Liver 44 (5) (2024)
Xiao-Dong Zhou, Wen-Yue Liu, Giovanni Targher, Christopher D Byrne, Ming-Hua Zheng
Letter: Drug interaction in resmetirom times. Alimentary pharmacology & therapeutics 60 (4) (2024)
Stergios A Polyzos, Giovanni Targher
Role of Glucocorticoids in Metabolic Dysfunction-Associated Steatotic Liver Disease. Current obesity reports 13 (2) (2024)
Christopher D Byrne, Giovanni Targher, Herbert Tilg
Thyroid hormone receptor-beta agonists: new MASLD therapies on the horizon. Gut 73 (4) (2024)
Ki Chul Sung, Tae Kyung Yoo, Mi-Yeon Lee, Christopher D Byrne, Ming-Hua Zheng, Giovanni Targher
Comparative Associations of Nonalcoholic Fatty Liver Disease and Metabolic Dysfunction-Associated Fatty Liver Disease With Coronary Artery Calcification: A Cross-Sectional and Longitudinal Cohort Study. Arteriosclerosis, thrombosis, and vascular biology 43 (3) (2023)
A-Na Liu, Cui-Fang Xu, Ya-Ru Liu, Dan-Qin Sun, Ling Jiang, Liang-Jie Tang, Pei-Wu Zhu, Sui-Dan Chen, Wen-Yue Liu, Xiao-Dong Wang, Giovanni Targher, Christopher D Byrne, Vincent Wai-Sun Wong, Junfen Fu, Ming-Ming Su, Stephen Caldwell, Ming-Hua Zheng, Yan Ni
Secondary bile acids improve risk prediction for non-invasive identification of mild liver fibrosis in nonalcoholic fatty liver disease. Alimentary pharmacology & therapeutics (2023)
Giovanni Targher
Editorial: Resmetirom - a promising treatment option for NASH and liver fibrosis. Alimentary pharmacology & therapeutics 59 (1) (2023)
Alessandro Mantovani, Herbert Tilg, Giovanni Targher
FGF-21 analogues for treatment of non-alcoholic steatohepatitis and fibrosis: a meta-analysis with fragility index of phase 2 randomised placebo-controlled trials. Gut (2023)
Martina Maurelli, Paolo Gisondi, Francesco Bellinato, Alessandro Mantovani, Giovanni Targher, Giampiero Girolomoni
Prevalence of Non-Alcoholic Fatty Liver Disease in Adult Individuals with Moderate-to-Severe Atopic Dermatitis. Journal of clinical medicine 12 (18) (2023)
Giovanni Targher
Editorial: Resmetirom - a promising treatment option for NASH and liver fibrosis. Alimentary pharmacology & therapeutics 59 (1) (2023)
Federico Ravaioli, Elton Dajti, Alessandro Mantovani, Philip Noel Newsome, Giovanni Targher, Antonio Colecchia
Diagnostic accuracy of FibroScan-AST (FAST) score for the non-invasive identification of patients with fibrotic non-alcoholic steatohepatitis: a systematic review and meta-analysis. Gut (2023)
Gong Feng, Xiaoxun Zhang, Liangjun Zhang, Wen-Yue Liu, Shi Geng, Hai-Yang Yuan, Jun-Cheng Sha, Xiao-Dong Wang, Dan-Qin Sun, Giovanni Targher, Christopher D Byrne, Tian-Lei Zheng, Feng Ye, Ming-Hua Zheng, Jin Chai, null null
Novel urinary protein panels for the non-invasive diagnosis of nonalcoholic fatty liver disease and fibrosis stages. Liver international : official journal of the International Association for the Study of the Liver (2023)
Ki Chul Sung, Tae Kyung Yoo, Mi-Yeon Lee, Christopher D Byrne, Ming-Hua Zheng, Giovanni Targher
Comparative Associations of Nonalcoholic Fatty Liver Disease and Metabolic Dysfunction-Associated Fatty Liver Disease With Coronary Artery Calcification: A Cross-Sectional and Longitudinal Cohort Study. Arteriosclerosis, thrombosis, and vascular biology (2023)
Huiling Zhan, Siyu Chen, Feng Gao, Guangxing Wang, Sui-Dan Chen, Gangqin Xi, Hai-Yang Yuan, Xiaolu Li, Wen-Yue Liu, Christopher D Byrne, Giovanni Targher, Miao-Yang Chen, Yong-Feng Yang, Jun Chen, Zhiwen Fan, Xitai Sun, Guorong Cai, Ming-Hua Zheng, Shuangmu Zhuo, null null
AutoFibroNet: A deep learning and multi-photon microscopy-derived automated network for liver fibrosis quantification in MAFLD. Alimentary pharmacology & therapeutics (2023)
Feng Gao, Christopher D Byrne, Giovanni Targher, Shuangmu Zhuo, Ming-Hua Zheng, null null
Editorial: Recent advances in fibrosis assessment for metabolic dysfunction-associated fatty liver disease-Authors' reply. Alimentary pharmacology & therapeutics 58 (6) (2023)
Norbert Stefan, Valentina Giampaoli, Giovanni Targher
Role of steatotic liver disease in prediction and prevention of cardiometabolic diseases. Nature reviews. Gastroenterology & hepatology (2023)
Tian-Lei Zheng, Jun-Cheng Sha, Qian Deng, Shi Geng, Shu-Yuan Xiao, Wen-Jun Yang, Christopher D Byrne, Giovanni Targher, Yang-Yang Li, Xiang-Xue Wang, Di Wu, Ming-Hua Zheng
Object detection: A novel AI technology for the diagnosis of hepatocyte ballooning. Liver international : official journal of the International Association for the Study of the Liver (2023)
Riccardo M Inciardi, Alessandro Mantovani, Giovanni Targher
Non-Alcoholic Fatty Liver Disease as an Emerging Risk Factor for Heart Failure. Current heart failure reports (2023)
Ki Chul Sung, Tae Kyung Yoo, Mi-Yeon Lee, Christopher D Byrne, Ming-Hua Zheng, Giovanni Targher
Comparative Associations of Nonalcoholic Fatty Liver Disease and Metabolic Dysfunction-Associated Fatty Liver Disease With Coronary Artery Calcification: A Cross-Sectional and Longitudinal Cohort Study. Arteriosclerosis, thrombosis, and vascular biology 43 (3) (2023)
Alessandro Mantovani, Serena Pelusi, Sara Margarita, Francesco Malvestiti, Michela Dell'Alma, Cristiana Bianco, Luisa Ronzoni, Daniele Prati, Giovanni Targher, Luca Vittorio Valenti
Adverse effect of PNPLA3 p.I148M genetic variant on kidney function in middle-aged individuals with metabolic dysfunction. Alimentary pharmacology & therapeutics (2023)
Alessandro Mantovani, Alessandro Csermely, Annalisa Castagna, Elisa Antinori, Elisa Danese, Chiara Zusi, Elena Sani, Federico Ravaioli, Antonio Colecchia, Claudio Maffeis, Luca Vittorio Valenti, Domenico Girelli, Giovanni Targher
Associations between higher plasma ferritin and hepcidin levels with liver stiffness in patients with type 2 diabetes: An exploratory study. Liver international : official journal of the International Association for the Study of the Liver (2023)
A-Na Liu, Cui-Fang Xu, Ya-Ru Liu, Dan-Qin Sun, Ling Jiang, Liang-Jie Tang, Pei-Wu Zhu, Sui-Dan Chen, Wen-Yue Liu, Xiao-Dong Wang, Giovanni Targher, Christopher D Byrne, Vincent Wai-Sun Wong, Junfen Fu, Ming-Ming Su, Stephen Caldwell, Ming-Hua Zheng, Yan Ni
Secondary bile acids improve risk prediction for non-invasive identification of mild liver fibrosis in nonalcoholic fatty liver disease. Alimentary pharmacology & therapeutics 57 (8) (2023)
Ki Chul Sung, Tae Kyung Yoo, Mi-Yeon Lee, Christopher D Byrne, Ming-Hua Zheng, Giovanni Targher
Comparative Associations of Nonalcoholic Fatty Liver Disease and Metabolic Dysfunction-Associated Fatty Liver Disease With Coronary Artery Calcification: A Cross-Sectional and Longitudinal Cohort Study. Arteriosclerosis, thrombosis, and vascular biology 43 (3) (2023)
Giovanni Targher
Editorial: Resmetirom - a promising treatment option for NASH and liver fibrosis. Alimentary pharmacology & therapeutics 59 (1) (2023)
Yang-Yang Li, Tian-Lei Zheng, Shu-Yuan Xiao, Peng Wang, Wen-Jun Yang, Li-Lin Jiang, Li-Li Chen, Jun-Cheng Sha, Yi Jin, Sui-Dan Chen, Christopher D Byrne, Giovanni Targher, Jian-Min Li, Ming-Hua Zheng
Hepatocytic ballooning in non-alcoholic steatohepatitis: Dilemmas and future directions. Liver international : official journal of the International Association for the Study of the Liver (2023)
A-Na Liu, Cui-Fang Xu, Ya-Ru Liu, Dan-Qin Sun, Ling Jiang, Liang-Jie Tang, Pei-Wu Zhu, Sui-Dan Chen, Wen-Yue Liu, Xiao-Dong Wang, Giovanni Targher, Christopher D Byrne, Vincent Wai-Sun Wong, Junfen Fu, Ming-Ming Su, Stephen Caldwell, Ming-Hua Zheng, Yan Ni
Secondary bile acids improve risk prediction for non-invasive identification of mild liver fibrosis in nonalcoholic fatty liver disease. Alimentary pharmacology & therapeutics 57 (8) (2023)
Christopher D Byrne, Giovanni Targher
Time to consider a holistic approach to the treatment of non-alcoholic fatty liver disease in obese young people? Gut (2022)
Alessandro Mantovani, Graziana Petracca, Alessandro Csermely, Giorgia Beatrice, Stefano Bonapace, Andrea Rossi, Herbert Tilg, Christopher D Byrne, Giovanni Targher
Non-alcoholic fatty liver disease and risk of new-onset heart failure: an updated meta-analysis of about 11 million individuals. Gut (2022)
Alessandro Mantovani, Alessandro Csermely, Herbert Tilg, Christopher D Byrne, Giovanni Targher
Comparative effects of non-alcoholic fatty liver disease and metabolic dysfunction-associated fatty liver disease on risk of incident cardiovascular events: a meta-analysis of about 13 million individuals. Gut (2022)
Alessandro Mantovani, Antonio Taverna, Davide Cappelli, Giorgia Beatrice, Alessandro Csermely, Elena Sani, Christopher D Byrne, Giovanni Targher
Long-Term Adverse Effect of Liver Stiffness on Glycaemic Control in Type 2 Diabetic Patients with Nonalcoholic Fatty Liver Disease: A Pilot Study. International journal of molecular sciences 23 (20) (2022)
Wenjing Xu, Changting Cui, Chunmei Cui, Zhenzhen Chen, Haizeng Zhang, Qinghua Cui, Guoheng Xu, Jianglin Fan, Yu Han, Liangjie Tang, Giovanni Targher, Christopher D Byrne, Ming-Hua Zheng, Liming Yang, Jun Cai, Bin Geng
Hepatocellular cystathionine γ lyase/hydrogen sulfide attenuates nonalcoholic fatty liver disease by activating farnesoid X receptor. Hepatology (Baltimore, Md.) 76 (6) (2022)
Gong Feng, Christopher D Byrne, Giovanni Targher, Fudi Wang, Ming-Hua Zheng
Ferroptosis and metabolic dysfunction-associated fatty liver disease: Is there a link? Liver international : official journal of the International Association for the Study of the Liver 42 (7) (2022)
Edoardo Mannucci, Marco Gallo, Andrea Giaccari, Riccardo Candido, Basilio Pintaudi, Giovanni Targher, Matteo Monami, null null
Effects of glucose-lowering agents on cardiovascular and renal outcomes in subjects with type 2 diabetes: An updated meta-analysis of randomized controlled trials with external adjudication of events. Diabetes, obesity & metabolism (2022)
Alessandro Mantovani, Chiara Zusi, Alessandro Csermely, Gian Luca Salvagno, Antonio Colecchia, Giuseppe Lippi, Claudio Maffeis, Giovanni Targher
Association between lower plasma adiponectin levels and higher liver stiffness in type 2 diabetic individuals with nonalcoholic fatty liver disease: an observational cross-sectional study. Hormones (Athens, Greece) 21 (3) (2022)
Alessandro Mantovani, Giovanni Targher
Editorial: higher levels of certain serum bile acids in non-alcoholic fatty liver disease-new insights from Guatemala. Alimentary pharmacology & therapeutics 56 (2) (2022)
Valentina Giampaoli, Alessandro Mantovani, Salvatore Petta, Amedeo Carraro, Christopher D Byrne, Giovanni Targher
Metabolic mechanisms for and treatment of NAFLD or NASH occurring after liver transplantation. Nature reviews. Endocrinology 18 (10) (2022)
Alessandro Mantovani, Alessandro Csermely, Elena Sani, Giorgia Beatrice, Graziana Petracca, Gianluigi Lunardi, Stefano Bonapace, Gian Luca Salvagno, Giovanni Targher
Association between Higher Circulating Leucine-Rich α-2 Glycoprotein 1 Concentrations and Specific Plasma Ceramides in Postmenopausal Women with Type 2 Diabetes. Biomolecules 12 (7) (2022)
Ting-Yao Wang, Rui-Fang Wang, Zhi-Ying Bu, Giovanni Targher, Christopher D Byrne, Dan-Qin Sun, Ming-Hua Zheng
Association of metabolic dysfunction-associated fatty liver disease with kidney disease. Nature reviews. Nephrology 18 (4) (2022)
Francesco Bellinato, Andrea Chiricozzi, Stefano Piaserico, Giovanni Targher, Paolo Gisondi
Could Targeted Pharmacotherapies Exert a "Disease Modification Effect" in Patients with Chronic Plaque Psoriasis? International journal of molecular sciences 23 (21) (2022)
Ines Zinterl, Till Ittermann, Sabine Schipf, Stefan Gross, Henryke Anspieler, Simon Kim, Ralf Ewert, Robin Bülow, Jens-Peter Kühn, Markus M Lerch, Henry Völzke, Stephan Burkhard Felix, Martin Bahls, Giovanni Targher, Marcus Dörr, Marcello Ricardo Paulista Markus
Low cardiopulmonary fitness is associated with higher liver fat content and higher gamma-glutamyltransferase concentrations in the general population - "The Sedentary's Liver". Liver international : official journal of the International Association for the Study of the Liver 42 (3) (2022)
Alessandro Giollo, Giulia Vinco, Giovanni Cioffi, Francesca Frizzera, Anna Quinternetto, Corinna Bergamini, Marta Dal Porto, Giovanni Orsolini, Margherita Zen, Andrea Doria, Davide Gatti, Flavio Luciano Ribichini, Giovanni Targher, Maurizio Rossini, Ombretta Viapiana
Subclinical Myocardial Fibrosis in Systemic Lupus Erythematosus as Assessed by Pulse-Cancellation Echocardiography: A Pilot Study. Journal of clinical medicine 11 (16) (2022)
Valentina Giampaoli, Alessandro Mantovani, Giovanni Targher, Gyorgy Baffy
Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease: Epidemiology, Pathogenesis, and Clinical and Research Implications. International journal of molecular sciences 23 (21) (2022)
Luisa Bonsembiante, Giovanni Targher, Claudio Maffeis
Type 2 Diabetes and Dietary Carbohydrate Intake of Adolescents and Young Adults: What Is the Impact of Different Choices? Nutrients 13 (10) (2021)
Alessandro Mantovani, Graziana Petracca, Giorgia Beatrice, Alessandro Csermely, Herbert Tilg, Christopher D Byrne, Giovanni Targher
Non-alcoholic fatty liver disease and increased risk of incident extrahepatic cancers: a meta-analysis of observational cohort studies. Gut (2021)
Alessandro Mantovani, Andrea Dalbeni, Denise Peserico, Filippo Cattazzo, Michele Bevilacqua, Gian Luca Salvagno, Gian Luca Salvagno, Giovanni Targher, Elisa Danese, Cristiano Fava
Plasma Bile Acid Profile in Patients with and without Type 2 Diabetes. Metabolites 11 (7) (2021)
Giovanni Targher
Concordance between MAFLD and NAFLD diagnostic criteria in 'real-world' data. Liver international : official journal of the International Association for the Study of the Liver 40 (11) (2021)
Feng Gao, Qiong He, Gang Li, Ou-Yang Huang, Liang-Jie Tang, Xiao-Dong Wang, Giovanni Targher, Christopher D Byrne, Jian-Wen Luo, Ming-Hua Zheng
A novel quantitative ultrasound technique for identifying non-alcoholic steatohepatitis. Liver international : official journal of the International Association for the Study of the Liver (2021)
Luisa Bonsembiante, Giovanni Targher, Claudio Maffeis
Non-alcoholic fatty liver disease in obese children and adolescents: a role for nutrition? European journal of clinical nutrition (2021)
Christopher D Byrne, Giovanni Targher
Non-alcoholic fatty liver disease-related risk of cardiovascular disease and other cardiac complications. Diabetes, obesity & metabolism (2021)
Josh Bilson, Eleonora Scorletti, Laure B Bindels, Paul R Afolabi, Giovanni Targher, Philip C Calder, Jaswinder K Sethi, Christopher D Byrne
Growth differentiation factor-15 and the association between type 2 diabetes and liver fibrosis in NAFLD. Nutrition & diabetes 11 (1) (2021)
Stefano Ballestri, Alessandro Mantovani, Enrica Baldelli, Simonetta Lugari, Mauro Maurantonio, Fabio Nascimbeni, Alessandra Marrazzo, Dante Romagnoli, Giovanni Targher, Valentina Giampaoli
Liver Fibrosis Biomarkers Accurately Exclude Advanced Fibrosis and Are Associated with Higher Cardiovascular Risk Scores in Patients with NAFLD or Viral Chronic Liver Disease. Diagnostics (Basel, Switzerland) 11 (1) (2021)

Giovanni Targher.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Giovanni Targher